233 related articles for article (PubMed ID: 8551474)
21. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
Wu HH; Wang NM; Cheng ML; Hsieh JN
Gynecol Endocrinol; 2007 Feb; 23(2):76-81. PubMed ID: 17454156
[TBL] [Abstract][Full Text] [Related]
22. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
[TBL] [Abstract][Full Text] [Related]
23. Double vs. single intrauterine insemination per cycle: use in gonadotropin cycles and in diagnostic categories of ovulatory dysfunction and male factor infertility.
Randall GW; Gantt PA
J Reprod Med; 2008 Mar; 53(3):196-202. PubMed ID: 18441725
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
[TBL] [Abstract][Full Text] [Related]
25. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
[TBL] [Abstract][Full Text] [Related]
26. Midcycle administration of single-dose GnRHa for luteal phase failure in women with ovarian hyperstimulation. A report of five cases.
Wu TC
J Reprod Med; 2000 Feb; 45(2):156-8. PubMed ID: 10710751
[TBL] [Abstract][Full Text] [Related]
27. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
Tan SL; Farhi J; Homburg R; Jacobs HS
Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
[TBL] [Abstract][Full Text] [Related]
28. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
[TBL] [Abstract][Full Text] [Related]
29. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
[TBL] [Abstract][Full Text] [Related]
30. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.
Romeu A; Monzó A; Peiró T; Diez E; Peinado JA; Quintero LA
J Assist Reprod Genet; 1997 Oct; 14(9):518-24. PubMed ID: 9401870
[TBL] [Abstract][Full Text] [Related]
31. Ovulation induction for in vitro fertilisation using clomiphene citrate and low-dose human menopausal gonadotrophin.
Ronen J; Bosschieter J; Wiswedel K; Hendriks S; Levin M
Int J Fertil; 1988; 33(2):120-2. PubMed ID: 2898449
[TBL] [Abstract][Full Text] [Related]
32. Comparison of endocrine and ultrasound profiles during ovulation induction with clomiphene citrate and letrozole in ovulatory volunteer women.
Jirge PR; Patil RS
Fertil Steril; 2010 Jan; 93(1):174-83. PubMed ID: 19028384
[TBL] [Abstract][Full Text] [Related]
33. Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate.
Sungurtekin U; Jansen RP
Fertil Steril; 1995 Mar; 63(3):663-5. PubMed ID: 7851604
[TBL] [Abstract][Full Text] [Related]
34. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial.
Penzias AS; Shamma FN; Gutmann JN; Jones EE; DeCherney AH; Lavy G
Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):739-42. PubMed ID: 1533022
[TBL] [Abstract][Full Text] [Related]
35. Luteinizing hormone-releasing hormone agonists for ovarian stimulation in assisted reproduction.
Tan SL
Curr Opin Obstet Gynecol; 1994 Apr; 6(2):166-72. PubMed ID: 8193257
[TBL] [Abstract][Full Text] [Related]
36. [Ovarian stimulation: a new approach based on recent physiological and clinical data. Future perspectives].
Lunenfeld B
Contracept Fertil Sex; 1993 Apr; 21(4 Suppl):1-7. PubMed ID: 7951638
[TBL] [Abstract][Full Text] [Related]
37. Risk of repeated spontaneous luteinizing hormone surges in ovarian stimulation for in vitro fertilization.
Nisker JA; Bloch CL; Tummon IS; Daniel SA; Yuzpe AA
J Reprod Med; 1993 Jun; 38(6):413-6. PubMed ID: 8331617
[TBL] [Abstract][Full Text] [Related]
38. Premature luteinization and ovulation induction using human menopausal gonadotrophin or pure follicle stimulating hormone in patients with polycystic ovary syndrome.
McFaul PB; Traub AI; Thompson W
Acta Eur Fertil; 1989; 20(3):157-61. PubMed ID: 2516391
[TBL] [Abstract][Full Text] [Related]
39. Does ovulation stimulation improve fertility in women with minimal/mild endometriosis after laser laparoscopy?
Kemmann E; Ghazi D; Corsan G; Bohrer MK
Int J Fertil Menopausal Stud; 1993; 38(1):16-21. PubMed ID: 8485606
[TBL] [Abstract][Full Text] [Related]
40. [Markers of the periovulatory phase with an eye toward insemination: E2/LH correlations].
Levrier M; Broussin B; Denechaud M; Ruffié A
Rev Fr Gynecol Obstet; 1985 Nov; 80(11):813-8. PubMed ID: 3937203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
